The impact of casirivimab-imdevimab antibody cocktail in patients amidst and post COVID 19 treatment: A retro-prospective comparative study in India

• Ngā kaituhi matua: Aneesh Puthiyedath Joy (Author), Anitha Theresa Augustine (Author), Mohammed Salim Karattuthodi (Author), Jaffer Chalil Parambil (Author), Dilip Chandrasekher (Author), P. Danisha (Author), Linu Mohan Panakkal (Author), Madhav A. Joshi (Author), K.T. Azharul Haque (Author), Irshad K. Mohammed Izudheen (Author), Shadia Badaruddeen (Author), Riya Sara John (Author), Sarath Murali (Author), Ardhra Rose Thomas (Author), Fathimath Sahla (Author), Shahir Ahmed KV. Ahmed Unni (Author), Raseel Omar Ahmed (Author), Shinu Cholamugath (Author)
• Hōputu: Pukapuka
• I whakaputaina: Elsevier, 2022-03-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background: Monoclonal antibodies have gained attention in developing countries owing to its benefits portrayed by few clinical trials. However, no studies until now have been undergone in India. Methods: A retro-prospective comparative observational study was conducted in symptomatic COVID19 patien...